Similar articles

• Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma.

  Coukell AJ, Spencer CM. Coukell AJ, et al. Drugs. 1997 Mar;53(3):520-38. doi: 10.2165/00003495-199753030-00011. Drugs. 1997. PMID: 9074848 Review.
• Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma.

  Amantea MA, Forrest A, Northfelt DW, Mamelok R. Amantea MA, et al. Clin Pharmacol Ther. 1997 Mar;61(3):301-11. doi: 10.1016/S0009-9236(97)90162-4. Clin Pharmacol Ther. 1997. PMID: 9084455 Clinical Trial.
• Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy.

  Northfelt DW, Dezube BJ, Thommes JA, Levine R, Von Roenn JH, Dosik GM, Rios A, Krown SE, DuMond C, Mamelok RD. Northfelt DW, et al. J Clin Oncol. 1997 Feb;15(2):653-9. doi: 10.1200/JCO.1997.15.2.653. J Clin Oncol. 1997. PMID: 9053490
• Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.

  Stewart S, Jablonowski H, Goebel FD, Arasteh K, Spittle M, Rios A, Aboulafia D, Galleshaw J, Dezube BJ. Stewart S, et al. J Clin Oncol. 1998 Feb;16(2):683-91. doi: 10.1200/JCO.1998.16.2.683. J Clin Oncol. 1998. PMID: 9469358 Clinical Trial.
• Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma.

  Udhrain A, Skubitz KM, Northfelt DW. Udhrain A, et al. Int J Nanomedicine. 2007;2(3):345-52. Int J Nanomedicine. 2007. PMID: 18019833 Free PMC article. Review.